Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old

.

Saved in:
Bibliographic Details
Main Author: article editorial
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2020-02-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/1796
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850046914730393600
author article editorial
author_facet article editorial
author_sort article editorial
collection DOAJ
description .
format Article
id doaj-art-04ebdbf89baa4f55b652d1b1cb220a46
institution DOAJ
issn 1727-5776
2500-3089
language Russian
publishDate 2020-02-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-04ebdbf89baa4f55b652d1b1cb220a462025-08-20T02:54:22ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892020-02-011661685Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years oldarticle editorial.https://www.pedpharma.ru/jour/article/view/1796
spellingShingle article editorial
Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
Педиатрическая фармакология
title Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
title_full Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
title_fullStr Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
title_full_unstemmed Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
title_short Novel treatment of systemic lupus erythematosus: belimumab is now available for Russian patients over 5 years old
title_sort novel treatment of systemic lupus erythematosus belimumab is now available for russian patients over 5 years old
url https://www.pedpharma.ru/jour/article/view/1796
work_keys_str_mv AT articleeditorial noveltreatmentofsystemiclupuserythematosusbelimumabisnowavailableforrussianpatientsover5yearsold